Vanguard Group
GRI

Vanguard Group’s GRI Bio GRI Stock Holding History

Vanguard Group’s Portfolio GRI Stock Details GRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$4.2K Hold
607
– – ﹤0.01% 4327
2025
Q3 		$35K Buy
+607
New +$28.1K ﹤0.01% 4322
2024
Q1 		– Hold
0
– -$7.14K – 4465
2023
Q4 		– Hold
0
– – – 4486
2023
Q3 		– Hold
0
– – – 4467
2022
Q4 		– Hold
0
– -$6K – 4538
2022
Q3 		– Hold
0
– – – 4602
2022
Q2 		– Hold
0
– – – 4616
2022
Q1 		– Hold
0
– – – 4543
2021
Q4 		– Hold
0
– – – 4268

Other funds holding GRI

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SG
StoneX Group New York $1.86B AUM 21.3% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group's GRI Position: Q4 2025 in Review

Vanguard Group held its GRI Bio (GRI) position steady in Q4 2025 at 607 shares worth $4.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4327.

Vanguard Group first reported a position in GRI in Q3 2025 and has held it in 2 quarters since. The position peaked at $35K in Q3 2025. 7 funds tracked by Wall St. Rank hold GRI as of Q4 2025.

  • Vanguard Group held 607 shares of GRI Bio worth $4.2K as of Q4 2025.
  • Vanguard Group left its GRI Bio share count unchanged in Q4 2025.
  • GRI Bio made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4327 holding.
  • Vanguard Group first reported a position in GRI Bio in Q3 2025 and has held it in 2 quarters since.
  • Vanguard Group's GRI Bio position peaked at $35K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held GRI Bio as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.